Kundansingh A. Pardeshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kundansingh A. Pardeshi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Harinath Chakrapani
Department of Chemistry Indian Institute of Science Education and Research Pune Pune Maharashtra India
4 shared publications - Govindan Ravikumar
Department of Chemistry, Indian Institute of Science Education and Research Pune, Dr. Homi Bhabha Road, Pashan, Pune, 411 008, Maharashtra, India
2 shared publications Ankita Banerjee
Vitas Pharma Research Private Limited, Technology Business Incubator, University of Hyderabad, C.R. Rao Road, Gachibowli, Hyderabad 500046, India
1 shared publication- Daniel K. Nomura
University of California, Berkeley
1 shared publication Eddie Wehri
The Henry Wheeler Center of Emerging and Neglected Diseases, 344 Li Ka Shing, Berkeley, CA, USA
1 shared publication- Elizabeth A. King
Department of Chemistry
1 shared publication
Latest Publications
- Open Access
- 9 June 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (26) , 17667-17677
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
The papain-like protease (PLpro) plays a critical role in SARS-CoV-2 (SCoV-2) pathogenesis and is essential for viral replication and for allowing the virus to evade the host immune response. Inhibitors of PLpro have great therapeutic potential, however, developing them has been challenging due to PLpro's restricted substrate binding pocket. In this report, we screened a 115 000-compound library for PLpro inhibitors and identified a new pharmacophore, based on a mercapto-pyrimidine fragment that is a reversible covalent inhibitor (RCI) of PLpro and inhibits viral replication in cells. Compound 5 had an IC50 of 5.1 μM for PLpro inhibition and hit optimization yielded a derivative with increased potency (IC50 0.85 μM, 6-fold higher). Activity based profiling of compound 5 demonstrated that it reacts with PLpro cysteines. We show here that compound 5 represents a new class of RCIs, which undergo an addition elimination reaction with cysteines in their target proteins. We further show that their reversibility is catalyzed by exogenous thiols and is dependent on the size of the incoming thiol. In contrast, traditional RCIs are all based upon the Michael addition reaction mechanism and their reversibility is base-catalyzed. We identify a new class of RCIs that introduces a more reactive warhead with a pronounced selectivity profile based on thiol ligand size. This could allow the expansion of RCI modality use towards a larger group of proteins important for human disease.
- 9 June 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (26) , 17667-17677
Open AccessMercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
The papain-like protease (PLpro) plays a critical role in SARS-CoV-2 (SCoV-2) pathogenesis and is essential for viral replication and for allowing the virus to evade the host immune response. Inhibitors of PLpro have great therapeutic potential, however, developing them has been challenging due to PLpro's restricted substrate binding pocket. In this report, we screened a 115 000-compound library for PLpro inhibitors and identified a new pharmacophore, based on a mercapto-pyrimidine fragment that is a reversible covalent inhibitor (RCI) of PLpro and inhibits viral replication in cells. Compound 5 had an IC50 of 5.1 μM for PLpro inhibition and hit optimization yielded a derivative with increased potency (IC50 0.85 μM, 6-fold higher). Activity based profiling of compound 5 demonstrated that it reacts with PLpro cysteines. We show here that compound 5 represents a new class of RCIs, which undergo an addition elimination reaction with cysteines in their target proteins. We further show that their reversibility is catalyzed by exogenous thiols and is dependent on the size of the incoming thiol. In contrast, traditional RCIs are all based upon the Michael addition reaction mechanism and their reversibility is base-catalyzed. We identify a new class of RCIs that introduces a more reactive warhead with a pronounced selectivity profile based on thiol ligand size. This could allow the expansion of RCI modality use towards a larger group of proteins important for human disease.
- 7 January 2019
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 30 (3) , 751-759
Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin
Fluoroquinolones (FQs) are among the front-line antibiotics used to treat severe infections caused by Gram-negative bacteria. However, recently, due to toxicity concerns, their use has been severely restricted. Hence, efforts to direct delivery of this antibiotic specifically to bacteria/site of infection are underway. Here, we report a strategy that uses a bacterial enzyme for activation of a prodrug to generate the active antibiotic. The ciprofloxacin-latent fluorophore conjugate 1, which is designed as a substrate for nitroreductase (NTR), a bacterial enzyme, was synthesized. Upon activation by NTR, release of Ciprofloxacin (CIP) as well as a fluorescence reporter was observed. We provide evidence for the prodrug permeating bacteria to generate a fluorescent signal and we found no evidence for activation in mammalian cells supporting selectivity of activation within bacteria. As a testament to its efficacy, 1 was found to have potent bactericidal activity nearly identical to CIP and significantly reduced the bacterial burden in a neutropenic mouse thigh infection model, again, at comparable potency with CIP, a clinically used FQ. Thus, together, we have developed a small molecule that facilitates bacteria-specific fluoroquinolone delivery.
- 7 January 2019
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 30 (3) , 751-759
Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin
Fluoroquinolones (FQs) are among the front-line antibiotics used to treat severe infections caused by Gram-negative bacteria. However, recently, due to toxicity concerns, their use has been severely restricted. Hence, efforts to direct delivery of this antibiotic specifically to bacteria/site of infection are underway. Here, we report a strategy that uses a bacterial enzyme for activation of a prodrug to generate the active antibiotic. The ciprofloxacin-latent fluorophore conjugate 1, which is designed as a substrate for nitroreductase (NTR), a bacterial enzyme, was synthesized. Upon activation by NTR, release of Ciprofloxacin (CIP) as well as a fluorescence reporter was observed. We provide evidence for the prodrug permeating bacteria to generate a fluorescent signal and we found no evidence for activation in mammalian cells supporting selectivity of activation within bacteria. As a testament to its efficacy, 1 was found to have potent bactericidal activity nearly identical to CIP and significantly reduced the bacterial burden in a neutropenic mouse thigh infection model, again, at comparable potency with CIP, a clinically used FQ. Thus, together, we have developed a small molecule that facilitates bacteria-specific fluoroquinolone delivery.
- Open Access
- 31 July 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (48) , 27359-27374
Small molecule generators of biologically reactive sulfur species
Reactive sulfur species (RSS) are integral to cellular survival and growth. Here, small molecule generators of RSS are reviewed.
- 31 July 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (48) , 27359-27374
Open AccessSmall molecule generators of biologically reactive sulfur species
Reactive sulfur species (RSS) are integral to cellular survival and growth. Here, small molecule generators of RSS are reviewed.
- 13 December 2017
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 20 (1) , 4-7
Esterase Sensitive Self-Immolative Sulfur Dioxide Donors
A series of cell-permeable esterase-sensitive sulfonates that undergo self-immolation to produce sulfur dioxide (SO2), a gaseous pollutant with new and emerging biological roles, is reported. These compounds should facilitate the study SO2 biology and will lay the platform for newer stimuli-responsive donors of this gas.
- 13 December 2017
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 20 (1) , 4-7
Esterase Sensitive Self-Immolative Sulfur Dioxide Donors
A series of cell-permeable esterase-sensitive sulfonates that undergo self-immolation to produce sulfur dioxide (SO2), a gaseous pollutant with new and emerging biological roles, is reported. These compounds should facilitate the study SO2 biology and will lay the platform for newer stimuli-responsive donors of this gas.
- 1 July 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (13) , 2694-2697
Thiol activated prodrugs of sulfur dioxide (SO2) as MRSA inhibitors
- 1 July 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (13) , 2694-2697
Thiol activated prodrugs of sulfur dioxide (SO2) as MRSA inhibitors